AQR Capital Management - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 88 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$565,000
-40.4%
13,633
-31.1%
0.00%
-50.0%
Q2 2020$948,000
-18.1%
19,784
+7.7%
0.00%0.0%
Q1 2020$1,157,000
-54.1%
18,369
-9.7%
0.00%
-33.3%
Q4 2019$2,522,000
+54.7%
20,352
-17.2%
0.00%
+50.0%
Q3 2019$1,630,000
-37.0%
24,570
-24.4%
0.00%
-33.3%
Q2 2019$2,586,000
-28.9%
32,504
-0.0%
0.00%
-25.0%
Q1 2019$3,636,000
+11.7%
32,507
+0.7%
0.00%0.0%
Q4 2018$3,255,000
+17.8%
32,296
+47.6%
0.00%
+33.3%
Q3 2018$2,764,000
+100.1%
21,877
+136.6%
0.00%
+50.0%
Q4 2015$1,381,000
+43.1%
9,247
+131.2%
0.00%0.0%
Q2 2015$965,000
+7.0%
3,999
+25.0%
0.00%0.0%
Q1 2015$902,000
-16.2%
3,200
-53.6%
0.00%0.0%
Q4 2014$1,076,000
-81.5%
6,900
-72.0%
0.00%
-87.5%
Q3 2014$5,823,000
+213.7%
24,600
+213.7%
0.02%
+220.0%
Q2 2014$1,856,000
+9.4%
7,843
+52.5%
0.01%0.0%
Q1 2014$1,696,000
+268.7%
5,143
-23.7%
0.01%
+400.0%
Q4 2013$460,000
-59.0%
6,743
-73.0%
0.00%
-75.0%
Q2 2013$1,121,00025,0000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2013
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders